Delivery Order SPE2DB20D2001-SPE2DB22FM72Y

Award Date 9/14/22
Potential Completion Date 9/15/22
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,470.24 firm-fixed-price contract is for the delivery of Latuda 20 mg tablets. This award is a part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) worth up to $999,999,999. The delivery order is for the supply of 120 mg Latuda tablets, a prescription medication used to treat mental health conditions. The contract is valued at $9,337.13 and has a firm fixed price. There is no set-aside designation mentioned. This IDC serves as a primary contract vehicle for...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Latuda 120 mg tablets. The contract has a ceiling value of $2,548.62 and a period of performance through August 25, 2023. It is a firm-fixed-price delivery order contract, with no set-aside requirements indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the prescription drug Latuda (40 mg tablets) with a ceiling value of $1,168.26 and a period of performance through August 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,087.12, is for the delivery of 60 mg Latuda tablets (national stock number 4565047371) with a period of performance through July 2, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,052.65, is for the delivery of LATUDA 120 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
This Federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Latuda 120 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,437.51 and a period of performance through February 3, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Latuda 80 mg tablets, a medication used to treat mental health conditions. The delivery order has a ceiling value of $1,956.47 and is a firm fixed-price contract with a completion date of December 3, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) worth...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Latuda 20 mg tablets. The $20,964.90 firm-fixed price contract has an ultimate completion date of April 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Latuda 20 mg tablets, a medication used to treat certain mental health conditions. The Delivery Order has a ceiling value of $3,458.41 and an ultimate completion date of May 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB22FM72Y
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The award is for the supply of the pharmaceutical product Latuda 20 mg tablets, with a ceiling value of $17,222.07 and a period of performance through September 15, 2022. The contract is a firm fixed-price, delivery order type, with no set-aside designation indicated. AmerisourceBergen, as the prime contractor, will be responsible for providing the requested medical product to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions served by the DLA. This contract is part of the DLA's broader efforts to ensure the availability of critical pharmaceutical supplies for the U.S. Department of Defense and other federal healthcare programs.

Generated 2/27/25, 10:35 AM